INTRODUCTION {#s1}
============

Cardiac excitation--contraction coupling, where an action potential elicits cardiomyocyte contraction, is mediated by 'Ca^2+^-induced Ca^2+^ release'. Upon plasma membrane depolarisation, Ca^2+^ influx through voltage-gated Ca^2+^ channels triggers Ca^2+^ release through the sarcoplasmic reticulum (SR)-located RyR2 to increase cytoplasmic Ca^2+^ concentration and transduce sarcomere contraction ([@JCS191643C4]). Termination of SR Ca^2+^ release is an incompletely understood process but appears to involve intra-SR luminal Ca^2+^ regulation of RyR2 channel activity ([@JCS191643C20]; [@JCS191643C27]). Luminal Ca^2+^ exerts its effects directly on RyR2 ([@JCS191643C7]) and through the cardiac SR Ca^2+^-binding protein CSQ2 ([@JCS191643C3]; [@JCS191643C9]; [@JCS191643C12]). Abnormal RyR2 regulation by luminal Ca^2+^ causes diastolic SR Ca^2+^ leak, resulting in arrhythmias and heart failure ([@JCS191643C12]; [@JCS191643C19]). Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an outstanding example of how arrhythmia induces sudden cardiac death by perturbing Ca^2+^ handling ([@JCS191643C5]). CPVT type 1 is linked to RyR2 mutations inherited in an autosomal-dominant manner, whereas CPVT type 2 is linked to both dominant and recessive mutations of calsequestrin 2 (CSQ2) (<http://triad.fsm.it/cardmoc/>).

RyR2 exists as a macromolecular complex composed of CSQ2 and the SR integral membrane proteins triadin and junctin (encoded by *ASPH*), which together form the luminal Ca^2+^ sensor ([@JCS191643C31]). CSQ2 interacts directly with both triadin and junctin in a Ca^2+^-dependent manner, with 1--5 mM Ca^2+^ inhibiting these interactions ([@JCS191643C23]; [@JCS191643C31]). Their binding sites have been mapped to the Asp-rich region at the C-terminus of CSQ2 and to the KEKE motif (residues 200--224) of triadin ([@JCS191643C16]; [@JCS191643C23]). Triadin and junctin interactions with RyR1 and RyR2 are also known to be direct, with the RyR2--junctin interaction being Ca^2+^-independent ([@JCS191643C11]; [@JCS191643C31]). The triadin KEKE motif interacts with negatively charged residues within the second luminal loop of RyR1 ([@JCS191643C10]; [@JCS191643C17]), whereas junctin association with the RyR1 or RyR2 involves both luminal and cytoplasmic sites ([@JCS191643C1]; [@JCS191643C18]). Evidence for direct RyR--CSQ association is very scarce. Interaction of calsequestrin 1 (CSQ1) with purified native skeletal muscle RyR1 has been reported ([@JCS191643C13]), which could have differential effects on channel activity depending on the presence of triadin and/or junctin ([@JCS191643C2]; [@JCS191643C25]). To our knowledge, there is no biochemical data for direct physical association between RyR2 and CSQ2 in the heart. Thus, although the functional association of RyR2 and CSQ2 is well established, this is generally believed to be indirectly mediated through triadin and junctin interactions ([@JCS191643C3]; [@JCS191643C9]; [@JCS191643C12]).

RESULTS AND DISCUSSION {#s2}
======================

Direct association of calsequestrin 2 with RyR2 {#s2a}
-----------------------------------------------

Initially, we investigated the native RyR2 interaction with recombinant purified CSQ2 using GST pull-down assays. GST alone was used as negative control and GST--FKBP12.6 (also known as FKBP1B) was used as a positive control. Purified (1 µM) GST-fusion protein was incubated with CHAPS-solubilised RyR2 from pig cardiac SR and isolated with glutathione Sepharose ([Fig. 1](#JCS191643F1){ref-type="fig"}A, bottom); the presence of co-precipitated RyR2 was analysed by immunoblotting using Ab^1093^ ([Fig. 1](#JCS191643F1){ref-type="fig"}A, top). RyR2 was efficiently co-precipitated by GST--CSQ2 and GST--FKBP12.6 but not by GST alone. The interaction of recombinant GST--CSQ2 with pig cardiac RyR2 might be direct or be mediated through the native-RyR2-associated proteins triadin, junctin and calsequestrin 2. To exclude an indirect interaction, we used recombinant human RyR2 expressed in HEK293 cells -- a non-cardiac cell line lacking endogenous junctin, triadin and CSQ2, as revealed by immunoblot analysis ([Fig. S1](Fig. S1)). Using GST pull-down assays, we found strong GST--CSQ2 binding to recombinant human RyR2 ([Fig. 1](#JCS191643F1){ref-type="fig"}B), indicating that triadin and junctin are non-essential for the RyR2--CSQ2 association. These experiments made use of purified CSQ2 expressed in bacteria that lack the machinery for glycosylation and phosphorylation, which are potential post-translational modifications for native calsequestrin 2. We therefore assessed the RyR2--CSQ2 interaction by performing co-immunoprecipitation assays following their co-expression in mammalian HEK293 cells. Hemagglutinin (HA)-tagged CSQ2 was immunoprecipitated with an antibody against HA from CHAPS-solubilised HEK293 cell lysates ([Fig. 1](#JCS191643F1){ref-type="fig"}C, bottom), and the presence of co-precipitated RyR2 was analysed by immunoblotting using Ab^1093^ ([Fig. 1](#JCS191643F1){ref-type="fig"}C, top). RyR2 was recovered from the anti-HA immunoprecipitate but not from the negative control using non-immune rabbit IgG. In the reverse experiment, immunoprecipitation of RyR2 with Ab^1093^ ([Fig. S2](Fig. S2), bottom) resulted in co-precipitation of HA--CSQ2 ([Fig. S2](Fig. S2), top), providing further evidence for direct complex formation between RyR2 and CSQ2. Our findings are consistent with previous work that indicates a physical association between the skeletal muscle isoforms, RyR1 and CSQ1, and that made use of purified native RyR1 with no detectable levels of endogenous triadin or junctin ([@JCS191643C2]; [@JCS191643C13]; [@JCS191643C25]). Fig. 1.**CSQ2 displays a direct interaction with RyR2.** (A) GST pull-down experiments (*n*=3) of native RyR2 incubated with purified GST-fusion proteins as indicated. Solubilised pig cardiac SR vesicles were incubated with purified GST-fusion proteins that had been captured on glutathione beads. Beads were precipitated by centrifugation, and the presence of associated RyR2 was analysed by SDS-PAGE (4% gel) and immunoblotting using the Ab^1093^ antibody (top). As negative control, pull-down assays were performed with GST alone. To detect the isolated GST-fusion proteins, one-tenth of pull-down samples was analysed by SDS-PAGE (12% gel) and immunoblotting using an antibody against GST (Ab^GST^, bottom). An aliquot of solubilised pig cardiac SR corresponding to 1% (5 μg) of the amount processed in the pull-down assay was also included in the gels. As a negative control, pulldown assays were performed with GST alone; GST--FKBP12.6 was used as positive control for RyR2 interaction. (B) GST pull-down experiments (*n*=3) of recombinant human RyR2 incubated with purified GST-fusion proteins as indicated. Solubilised HEK293 microsomes expressing RyR2 (HEK micro) were incubated with purified GST-fusion proteins captured on glutathione beads, and analysed as described in A above. (C) Co-immunoprecipitation (co-IP) analyses (*n*=3) of recombinant human RyR2 co-expressed with CSQ2 in mammalian HEK293 cells. HA--CSQ2 was immunoprecipitated with an antibody against HA (Ab^HA^) from solubilised HEK293 lysates, and the presence of associated RyR2 was analysed by SDS-PAGE (4% gel) and immunoblotting using Ab^1093^ (top). As negative control, co-immunoprecipitation assays were performed with non-immune rabbit IgG (Non-immune). To detect isolated HA--CSQ2, one-tenth of the immunoprecipitate was analysed by SDS-PAGE (12% gel) and western blotting (WB) using an antibody against HA (Ab^HA^, bottom). An aliquot of HEK293 cell lysate corresponding to 1% (20 μg) of the amount processed in the co-immunoprecipitation assay was also included in the gels.

CSQ2 interacts with the first luminal loop of RyR2 {#s2b}
--------------------------------------------------

The direct interaction of CSQ2 can only occur with RyR2 peptide sequences that face the SR lumen. To map the CSQ2-binding site, we used four overlapping fragments covering the RyR2 C-terminus containing all the transmembrane domains and intervening luminal loops (BT constructs shown in [Fig. 2](#JCS191643F2){ref-type="fig"}A). HA--CSQ2, co-expressed with Myc-tagged BT1D, BT1D2, BT1B2 and BT9 constructs (see Fig. 2A) in HEK293 cells, was immunoprecipitated with an antibody against HA from CHAPS-solubilised cell lysates ([Fig. 2](#JCS191643F2){ref-type="fig"}B, bottom), and the presence of co-precipitated BT constructs was analysed by immunoblotting using an antibody against Myc ([Fig. 2](#JCS191643F2){ref-type="fig"}B, top). BT1D2 was the only RyR2 fragment recovered in the anti-HA immunoprecipitate but not in the negative control using non-immune rabbit IgG. The shorter BT1D construct that lacks the first two transmembrane domains and intervening luminal loop was found to be negative for an interaction with CSQ2. To further test whether the CSQ2-binding site is contained within the RyR2 first luminal loop (LL1), we generated the RyR2 LL1 fragment (residues 4521--4573) as a GST-fusion protein (GST-LL1) purified from bacteria for use in pull-down assays; we were unable to use the LL1 construct in coimmunoprecipitation assays because it was expressed very poorly in HEK293 cells. Purified (1 µM) GST-fusion protein was incubated with CHAPS-solubilised HEK293 cell lysate expressing HA--CSQ2 and isolated with glutathione Sepharose ([Fig. 2](#JCS191643F2){ref-type="fig"}C, bottom); the presence of co-precipitated HA--CSQ2 was analysed by immunoblotting using an antibody against HA ([Fig. 2](#JCS191643F2){ref-type="fig"}C, top). HA--CSQ2 was efficiently pulled down by GST--LL1, whereas binding to GST alone, serving as negative control, was negligible. To further assess whether the CSQ2-binding site is contained within the RyR2 first luminal loop, we conducted competition binding experiments to test whether GST--LL1 disrupted the CSQ2 interaction with the full-length RyR2. RyR2 was co-expressed with HA--CSQ2 in HEK293 cells, and co-immunoprecipitation assays were performed in the presence of 1 µM GST--LL1 or GST alone. As seen in [Fig. 2](#JCS191643F2){ref-type="fig"}D, in the presence of GST alone, RyR2 was efficiently recovered in the anti-HA immunoprecipitate, whereas the inclusion of GST--LL1 abolished the RyR2 interaction with HA--CSQ2. Fig. 2.**Mapping the CSQ2-interacting site on RyR2.** (A) Human RyR2 SR membrane topology (right) and diagram of overlapping BT1D, BT1D2, BT1B2 and BT9 constructs covering the RyR2 C-terminus containing all the transmembrane domains and intervening luminal loops. M indicates membrane-spanning domains. (B) Co-immunoprecipitation (co-IP) experiments (*n*=4) of recombinant human RyR2 fragments co-expressed with CSQ2 in HEK293 cells. HA--CSQ2 was immunoprecipitated with an antibody against HA (Ab^HA^) from solubilised HEK293 lysates that co-expressed Myc-tagged BT constructs. As negative control, co-immunoprecipitation assays were performed with non-immune rabbit IgG (non-immune). Immunoprecipitated proteins were resolved in separate SDS-PAGE gels (12% for BT1D and BT1D2, 15% for BT1B2 and BT9, and 12% for HA--CSQ2) loaded with nine-tenths or one-tenth of the immunoprecipitates and were analysed by immunoblotting using antibodies against Myc (Ab^cMyc^, top) or HA (Ab^HA^, bottom), respectively. An aliquot of HEK293 cell lysate corresponding to 1% (20 μg) of the amount processed in the co-immunoprecipitation assay was also included in the gels. (C) GST pull-down experiments (*n*=4) of recombinant human CSQ2 incubated with purified GST--LL1 (RyR2 residues 4521--4573) or GST alone serving as negative control. Solubilised HEK293 lysates expressing HA--CSQ2 were incubated with purified GST-fusion proteins captured on glutathione beads. Precipitated proteins were resolved in separate 12% SDS-PAGE gels loaded with nine-tenths or one-tenth of the pull-down samples and were analysed by immunoblotting for HA (Ab^HA^, top) or GST (Ab^GST^, bottom), respectively. (D) Competition binding experiments (*n*=3) to test the RyR2--CSQ2 interaction. HA--CSQ2 was immunoprecipitated with an antibody against HA (Ab^HA^) from solubilised HEK293 lysates co-expressing RyR2 in the presence of GST--LL1 or GST alone (negative control). Immunoprecipitated proteins were resolved in separate 4% or 12% SDS-PAGE gels loaded with nine-tenths or one-tenth of the immunoprecipitates and were analysed by immunoblotting with Ab^1093^ (top) and for HA (Ab^HA^, bottom), respectively. (E) Co-immunoprecipitation experiments (*n*=4) of BT1D2 co-expressed with CSQ2 in HEK293 cells, performed under different Ca^2+^ concentrations. HA--CSQ2 was immunoprecipitated with an antibody against HA (Ab^HA^) from solubilised HEK293 lysates containing either 1 mM EGTA, 100 µM CaCl~2~, 1 mM CaCl~2~ or 5 mM CaCl~2~, as indicated. The presence of co-precipitated BT1D2 was analysed by SDS-PAGE (10% gels) and immunoblotting for Myc (Ab^cMyc^, top) or HA (Ab^HA^, bottom), respectively.

The experiments described above were conducted using assay buffers containing residual, micromolar Ca^2+^. Further investigation of the Ca^2+^ sensitivity of the RyR2--CSQ2 interaction was performed in the presence of near-physiological SR Ca^2+^ concentrations (1 mM CaCl~2~), or in the absence of Ca^2+^ (1 mM EGTA), as well as under conditions of high (5 mM CaCl~2~) or low (100 µM CaCl~2~) SR Ca^2+^ load. Using co-immunoprecipitation assays, we found comparable amounts of BT1D2 binding to HA--CSQ2 in the presence of 1 mM EGTA, and 100 µM and 1 mM CaCl~2~; however, recovery of BT1D2 in the anti-HA immunoprecipitate was diminished with 5 mM CaCl~2~ ([Fig. 2](#JCS191643F2){ref-type="fig"}E). Quantitative data (*n*=4) following densitometry analysis and normalisation for the amount of protein expressed in the cell lysate indicate equivalent amounts of HA--CSQ2 binding to BT1D2 for Ca^2+^ concentrations up to 1 mM (1 mM EGTA, 154.2±20.8; 100 µM CaCl~2~, 126.7±30.5; 1 mM CaCl~2~, 149.0±43.5; mean±s.e.m.); however, 5 mM CaCl~2~ substantially reduced binding by \>50% (71.5±36.9, *P*\<0.05 two-tailed paired Student\'s *t*-test compared to 1 mM CaCl~2~). These results suggest that at Ca^2+^ levels within the physiological SR range (≤1 mM), the RyR2--CSQ2 interaction remains intact but that it is diminished at supra-millimolar Ca^2+^ levels, in agreement with previous reports ([@JCS191643C3]; [@JCS191643C9]). Our data are also consistent with recent single-channel recordings demonstrating that CSQ2 effects on RyR2 activity are unaffected by luminal Ca^2+^ concentration changes up to 1 mM ([@JCS191643C6]; [@JCS191643C26]). CSQ2 undergoes structural changes upon Ca^2+^ binding and polymerises at \>1 mM Ca^2+^ concentrations; it is believed that a front-to-front CSQ2 dimer is first formed, with these dimers forming a back-to-back stack to produce a polymeric structure ([@JCS191643C9]). Our findings suggest that the RyR2-interacting site on CSQ2 assumes a Ca^2+^-independent conformation that might be obstructed if CSQ2 is in its polymeric form. They further indicate that monomeric CSQ2 is sufficient for direct RyR2 interaction.

Direct CSQ2 association with RyR2 regulates cellular Ca^2+^- release dynamics {#s2c}
-----------------------------------------------------------------------------

Expression of RyR2 in HEK293 cells is known to result in spontaneous global Ca^2+^-release events ([@JCS191643C14]; [@JCS191643C22]). To assess the functional impact of CSQ2 on RyR2 in the absence of triadin and junctin, we generated HEK293 cells that stably expressed CSQ2, verified by immunoblotting ([Fig. S1](Fig. S1)). Co-expression of RyR2 in the CSQ2-expressing stable cell line resulted in an increase in the duration between Ca^2+^-release events (inter-transient duration), decreasing their overall frequency ([Fig. 3](#JCS191643F3){ref-type="fig"}A,F,G), compared to that in cells that expressed RyR2 alone. Rates of transient rise and decay were also slower ([Fig. 3](#JCS191643F3){ref-type="fig"}C,D), lengthening the overall duration of Ca^2+^ release ([Fig. 3](#JCS191643F3){ref-type="fig"}E), with no significant change in amplitude ([Fig. 3](#JCS191643F3){ref-type="fig"}B). These whole-cell functional results provide further evidence for a direct RyR2--CSQ2 interaction and corroborate our biochemical findings. Notably, our results are consistent with the previously reported inhibitory action of this luminal accessory protein in cardiomyocytes, where CSQ2 would associate with RyR2 both directly and indirectly through junctin and triadin. The decrease in Ca^2+^-release event frequency ([Fig. 3](#JCS191643F3){ref-type="fig"}G) that we observed agrees with that reported in most CSQ2-overexpression studies ([@JCS191643C15]; [@JCS191643C21]; [@JCS191643C28]; [@JCS191643C29]). The longer inter-transient duration ([Fig. 3](#JCS191643F3){ref-type="fig"}F) is also consistent with the increase in Ca^2+^-binding sites within the store provided by CSQ2, indicating that more time is required to reach a high-enough level of free luminal Ca^2+^ to trigger the next Ca^2+^-release event ([@JCS191643C14]). In addition, it has been reported that although RyR2 activity decreases when CSQ2 is dissociated ([@JCS191643C30]), the relative open probability increases more steeply with luminal Ca^2+^ after CSQ2 dissociation ([@JCS191643C8]), in agreement with our findings that the rate of spontaneous Ca^2+^ release is increased in the absence of CSQ2 ([Fig. 3](#JCS191643F3){ref-type="fig"}C). Thus, although we cannot exclude the involvement of junctin and triadin, our data obtained in a cell line devoid of these accessory proteins suggest that the functional effects of CSQ2 are mediated primarily through its direct structural interaction with RyR2. Fig. 3.**Direct interaction of CSQ2 with RyR2 alters intracellular Ca^2+^ release.** Traces from Fluo-3-AM-loaded single HEK293 cells expressing RyR2 alone or RyR2 together with CSQ2, showing spontaneous Ca^2+^ release under conditions with 1.3 mM extracellular Ca^2+^ (A). Parameters of Ca^2+^-release events, including amplitude (B), rate of release (C), rate of decay (D), duration (E), inter-transient duration (F) and frequency (G) were analysed for *n*=18-- 24 cells from three or four separate experiments. \*Significant difference by unpaired Student\'s *t*-test, where *P*\<0.005. Data are means±s.e.m. F denotes fluorescence; f.u. denotes fluorescence units.

In conclusion, our data indicate a direct functional RyR2 interaction with CSQ2, shedding more light on the quaternary structural assembly of the SR luminal Ca^2+^ sensor. Elucidation of the CSQ2-binding site within the first luminal loop of RyR2 should help in further understanding the pathologic mechanism(s) underlying arrhythmias and sudden cardiac death.

MATERIALS AND METHODS {#s3}
=====================

Materials {#s3a}
---------

Cell culture reagents and Fluo-3 AM were obtained from Life Technologies, electrophoresis equipment and reagents from Bio-Rad, protease inhibitor cocktail (Complete) from Roche, CHAPS from Merck, nProtein-A Sepharose and glutathione Sepharose 4B from GE Healthcare, secondary antibodies from Santa Cruz Biotechnology, enhanced chemiluminescence reagents from Pierce, DNA restriction endonucleases from New England Biolabs, Pfu DNA polymerase from Promega, oligonucleotides and all other reagents were from Sigma. Antibodies used for immunoprecipitation: (1 μg) rabbit anti-HA antibody (Y-11, cat. no. sc-805, 1:40 dilution for immunoprecipitation) and non-immune rabbit IgG were from Santa Cruz Biotechnology. Antibodies used in immunoblotting were mouse anti-Myc (9E10, cat. no. sc-40, 1:500 dilution for western blotting) from Santa Cruz Biotechnology, mouse anti-HA (16B12, cat. no. MMS-101, 1:1000 dilution for western blotting) from Covance; rabbit anti-GST (1:2000) ([@JCS191643C33], [@JCS191643C32]), and rabbit RyR2-specific (Ab^1093^, epitope at residues 4454-4474; 1:500) ([@JCS191643C33], [@JCS191643C32]) antibodies.

Plasmid construction {#s3b}
--------------------

Human CSQ2 cDNA containing the entire open reading was generated by performing PCR amplification from a human heart cDNA library (Clontech) and was cloned into the bacterial expression vector pGEX6P1 (GE Healthcare). For transient mammalian expression, CSQ2 cDNA was subcloned into a modified pCR3 vector (Life Technologies) containing an N-terminal HA peptide epitope tag, whereas for stable expression, it was cloned into pcDNA3.1^(+)^hygro (Life Technologies). Human RyR2 constructs were generated by performing PCR amplification \[using human (h)RyR2 cDNA as template\] and cloning into a modified pCR3 vector containing an N-terminal Myc peptide epitope tag. For bacterial expression of the LL1 construct, the cDNA was subcloned into the pGEX6P1 vector. Oligonucleotide primers and restriction enzyme cloning sites used are available upon request. All plasmids were verified by direct DNA sequencing (BigDye, Perkin-Elmer).

Mammalian cell culture and transfection {#s3c}
---------------------------------------

HEK293 cells (ATCC^®^) were cultured in Dulbecco\'s modified Eagle\'s medium supplemented with 2 mM glutamine and 10% fetal bovine serum under a humidified atmosphere of 5% CO~2~ at 37°C. On reaching ∼70% confluence, cells growing on a 100-mm Petri dish were transiently transfected with 24 μg of plasmid DNA using the calcium phosphate precipitation method, as described elsewhere ([@JCS191643C24]). Cells were collected 24 h post-transfection and stored at −80°C. Transfected cells were also used to generate a clonally-derived CSQ2 stable cell line using limiting dilution with selection using hygromycin (400 µg ml^−1^). For Ca^2+^ imaging, stable cells from this clonal population were transiently transfected with eGFP--hRyR2 using Effectene^®^ (Qiagen) according to the manufacturer\'s instructions.

Single cell Ca^2+^-imaging {#s3d}
--------------------------

Cells stably expressing CSQ2 (∼1×10^5^) were seeded onto poly-lysine-coated glass-bottomed dishes (MatTek™) before transient transfection with eGFP--hRyR2. After 48 h, cells were loaded with Fluo-3 AM (10 µM) for 45 min at 30°C. Following de-esterification, cells were immersed in Krebs-Ringer-Hepes buffer for imaging (120 mM NaCl, 5.5 mM glucose, 25 mM Hepes, 4.8 mM KCl, 1.2 mM KH~2~PO~4~, 1.2 mM MgSO~4~, 1.3 mM CaCl~2~, pH 7.4). RyR2-mediated spontaneous Ca^2+^-release events were monitored using a laser scanning confocal microscope (Leica SP5) with an oil immersion 63× objective lens with excitation at 488 nm, and Ca^2+^-dependent fluorescence emission was detected over a 520±28 nm range. Using Leica Microsystems software (LAS-AF), Ca^2+^-release events were recorded for 2 min (five frames per second) at 512×512 pixel resolution, and acquired regions of interest representing global Ca^2+^ environments (typically ∼50 μm^2^) were selected. Amplitude and temporal characteristics of spontaneous Ca^2+^ release were quantified and are displayed as means±s.e.m. Statistical analysis was performed using unpaired Student\'s *t*-test.

Other methods {#s3e}
-------------

Bacterial expression and purification of GST-fusion proteins, GST pull-down and co-immunoprecipitation assays, SR preparation and immunoblotting were performed as described previously ([@JCS191643C24]; [@JCS191643C33], [@JCS191643C32]). Densitometry analysis was performed using a GS-700 scanner (Bio-Rad) and Quantity One software (Bio-Rad); data are expressed as means±s.e.m. and statistical analysis was performed using paired Student\'s *t*-test.
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